Contingency Management
Contingency management (CM) is a powerful behavioral strategy that has repeatedly been demonstrated to reduce stimulant use by individuals with Stimulant Use Disorder. Use of CM outside of the VA has been rare due to regulatory and funding obstacles. However, CM is cited in the 2022 National Drug Plan as a priority treatment to address the treatment needs of individuals with cocaine and methamphetamine use disorder. Delivery of an effective, evidence-based CM protocol that is in compliance with federal guidelines requires careful development of a training and implementation plan. The presenter will present the steps and key components of the CM protocol and implementation plan being used in California in the first large scale implementation of CM outside the VA.
Audience:
Prescribing clinicians and their teams
Continuing Medical Education
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Maine Medical Education Trust and CCSME. The Maine Medical Education Trust is accredited by the Maine Medical Association Committee on Continuing Medical Education and Accreditation to provide continuing medical education for physicians.
Contact Hours
1.5 contact hours for social workers, licensed clinical professional counselors, and behavioral health professionals
1.5 Category I contact hour for psychologists are provided. CCSME is a pre-approved sponsor and provider of Professional Education Activities for Psychologists.
1.5 contact hour CHES. CCSME is a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc.
1.5 contact hour pending for alcohol and drug counselors from the board of alcohol and drug counselors
Speaker
-
Richard RawsonPh.D.Dr. Rawson is an Emeritus Professor in the Department of Psychiatry and Biobehavioral Science, UCLA School of Medicine and a Research Professor at the University of Vermont. He received his Ph.D. in experimental psychology from the University of Vermont in 1970. He has conducted an extensive portfolio of research on methamphetamine, including projects on behavioral and medication treatments, with brain imaging measures. He was a member of the Federal Methamphetamine Advisory Group for Attorney General Janet Reno. During the past decade, he has worked with NIDA, SAMHSA, the US State Department, the World Health Organization and the United Nations Office of Drugs and Crime on international substance abuse research and training projects, exporting US technology and addiction science throughout the world. Dr. Rawson has published 3 books, 40 book chapters and over 240 professional papers and annually conducts numerous workshops, paper presentations and training sessions.
